| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.017 | 0.7 |